New Zealand markets closed

Quest Diagnostics Incorporated (DGX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
132.01+0.95 (+0.72%)
As of 10:06AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 14.51B
Enterprise value 19.32B
Trailing P/E 17.50
Forward P/E 14.90
PEG ratio (5-yr expected) 1.55
Price/sales (ttm)1.60
Price/book (mrq)2.30
Enterprise value/revenue 2.09
Enterprise value/EBITDA 11.16

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-5.91%
S&P500 52-week change 329.57%
52-week high 3148.62
52-week low 3119.59
50-day moving average 3127.85
200-day moving average 3132.03

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 3865.27k
Shares outstanding 5110.71M
Implied shares outstanding 6110.71M
Float 8109.71M
% held by insiders 10.86%
% held by institutions 192.03%
Shares short (15 Mar 2024) 42.65M
Short ratio (15 Mar 2024) 42.54
Short % of float (15 Mar 2024) 43.15%
Short % of shares outstanding (15 Mar 2024) 42.39%
Shares short (prior month 15 Feb 2024) 42.97M

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 42.29%
Trailing annual dividend rate 32.84
Trailing annual dividend yield 32.17%
5-year average dividend yield 41.91
Payout ratio 437.25%
Dividend date 322 Apr 2024
Ex-dividend date 405 Apr 2024
Last split factor 22:1
Last split date 321 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.23%
Operating margin (ttm)12.94%

Management effectiveness

Return on assets (ttm)6.21%
Return on equity (ttm)14.62%

Income statement

Revenue (ttm)9.25B
Revenue per share (ttm)82.61
Quarterly revenue growth (yoy)-1.90%
Gross profit (ttm)N/A
EBITDA 1.77B
Net income avi to common (ttm)850M
Diluted EPS (ttm)7.48
Quarterly earnings growth (yoy)90.10%

Balance sheet

Total cash (mrq)686M
Total cash per share (mrq)6.2
Total debt (mrq)5.5B
Total debt/equity (mrq)85.66%
Current ratio (mrq)1.31
Book value per share (mrq)56.82

Cash flow statement

Operating cash flow (ttm)1.27B
Levered free cash flow (ttm)662.88M